• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAA 0.00% 18.0¢

PHARMAUST LIMITED - Announcements

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

Announcements


Filters [Clear]
  • Price Sensitive: Yes
PAA Demonstration batch of smaller size MPL tablets completedPRICE SENSITIVE01/12/21 download Created with Sketch. 275.41KB
PAA MND & COVID-19 Phase 1 Clinical Trials On-TrackPRICE SENSITIVE17/11/21 download Created with Sketch. 218.35KB
PAA Canine phase 2b cancer trial expands to New ZealandPRICE SENSITIVE15/11/21 download Created with Sketch. 234.84KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE29/10/21 download Created with Sketch. 654.8KB
PAA MPL Manufacturing and Human Trials UpdatePRICE SENSITIVE21/10/21 download Created with Sketch. 223.25KB
PAA Following Extension of Survival, PAA Prepares Phase 3 TrialPRICE SENSITIVE18/10/21 download Created with Sketch. 247.8KB
PAA ProspectusPRICE SENSITIVE01/10/21 download Created with Sketch. 310.07KB
PAA Entitlement Options OfferPRICE SENSITIVE01/10/21 download Created with Sketch. 146.97KB
PAA Epichem Completes Final Loan RepaymentPRICE SENSITIVE31/08/21 download Created with Sketch. 224.72KB
PAA Appendix 4E & Full Year Statutory AccountsPRICE SENSITIVE18/08/21 download Created with Sketch. 1.12MB
PAA Epichem Completes Build of OHD Benchtop Flow ReactorPRICE SENSITIVE03/08/21 download Created with Sketch. 211.58KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE28/07/21 download Created with Sketch. 522.09KB
PAA Monepantel and monepantel sulfone COVID-19 anti-viral updatePRICE SENSITIVE26/07/21 download Created with Sketch. 503.52KB
PAA PharmAust and WEHI to Investigate HTLV-1 Viral InfectionsPRICE SENSITIVE12/07/21 download Created with Sketch. 410.42KB
PAA Phase IIb Dog Trial Achieves Interim Clinical EndpointsPRICE SENSITIVE28/06/21 download Created with Sketch. 447.83KB
PAA PharmAust receives ethics approval for Phase I trial in MNDPRICE SENSITIVE02/06/21 download Created with Sketch. 272.66KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE29/04/21 download Created with Sketch. 305.76KB
PAA Phase IIb Canine Trial Identifies Therapeutic Window for MPLPRICE SENSITIVE27/04/21 download Created with Sketch. 367.01KB
PAA PharmAust Receives $750k R&D Tax Incentive RefundPRICE SENSITIVE08/04/21 download Created with Sketch. 348.54KB
PAA Leiden Testing Indicates MPL SARS-CoV-2 Antiviral ActivityPRICE SENSITIVE07/04/21 download Created with Sketch. 531.65KB
PAA Trading HaltPRICE SENSITIVE06/04/21 download Created with Sketch. 412.74KB
PAA Pause in TradingPRICE SENSITIVE06/04/21 download Created with Sketch. 116.36KB
PAA Update on Phase IIb Clinical Trial of Monepantel in Pet DogsPRICE SENSITIVE30/03/21 download Created with Sketch. 392.54KB
PAA Licensing Agreement to Develop Waste to Fuels TechnologyPRICE SENSITIVE23/03/21 download Created with Sketch. 324.8KB
PAA Appendix 4D & Half Year ReportPRICE SENSITIVE26/02/21 download Created with Sketch. 523.81KB
PAA Update on Phase IIb Clinical Trial recruitmentPRICE SENSITIVE15/02/21 download Created with Sketch. 346.6KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE27/01/21 download Created with Sketch. 490.75KB
PAA Epichem Awarded $200K WasteSorted e-Waste GrantPRICE SENSITIVE22/01/21 download Created with Sketch. 389.54KB
PAA Leiden University Medical Centre Monepantel COVID-19 TestingPRICE SENSITIVE08/01/21 download Created with Sketch. 408.85KB
PAA PAA & ONJCRI to Continue MPL Pre-clinical InvestigationsPRICE SENSITIVE05/01/21 download Created with Sketch. 400.86KB
PAA PAA Commences Manufacture of GMP-Grade MPL for Human TrialsPRICE SENSITIVE23/12/20 download Created with Sketch. 388.13KB
PAA PharmAust to Commence Phase IIb Dog Cancer TrialPRICE SENSITIVE22/12/20 download Created with Sketch. 369.9KB
PAA Epichem Awarded Contract Extension from DNDiPRICE SENSITIVE21/12/20 download Created with Sketch. 402.45KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE29/10/20 download Created with Sketch. 275.91KB
PAA ONJCRI Evaluates Monepantel Anti-Cancer MechanismPRICE SENSITIVE29/09/20 download Created with Sketch. 390.86KB
PAA PAA Evaluate MPL Suitability for Ex-Vivo Human COVID-19 TestPRICE SENSITIVE24/09/20 download Created with Sketch. 407.01KB
PAA PAA awarded grant for Phase I trial in Motor Neurone DiseasePRICE SENSITIVE21/09/20 download Created with Sketch. 406.07KB
PAA PharmAust Shareholder UpdatePRICE SENSITIVE14/09/20 download Created with Sketch. 330.82KB
PAA Monepantel Anti-viral Activity Against SARS-CoV-2 ConfirmedPRICE SENSITIVE09/09/20 download Created with Sketch. 398.64KB
PAA Elanco Option UpdatePRICE SENSITIVE09/09/20 download Created with Sketch. 373.81KB
PAA Trading HaltPRICE SENSITIVE07/09/20 download Created with Sketch. 536.33KB
PAA Epichem in partnership to develop waste into fuel technologyPRICE SENSITIVE01/09/20 download Created with Sketch. 368.83KB
PAA Appendix 4E & Preliminary Final ReportPRICE SENSITIVE31/08/20 download Created with Sketch. 313.61KB
PAA Inhibition of SARS-CoV-2 by MPL in Human Respiratory CellsPRICE SENSITIVE25/08/20 download Created with Sketch. 421.74KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE28/07/20 download Created with Sketch. 475.64KB
PAA PharmAust Shareholder UpdatePRICE SENSITIVE24/06/20 download Created with Sketch. 955.83KB
PAA Reinstatement to Official QuotationPRICE SENSITIVE18/06/20 download Created with Sketch. 71.7KB
PAA Confirmation of Preliminary COVID-19 ResultsPRICE SENSITIVE18/06/20 download Created with Sketch. 868.39KB
PAA Voluntary SuspensionPRICE SENSITIVE15/06/20 download Created with Sketch. 183.09KB
PAA Trading HaltPRICE SENSITIVE11/06/20 download Created with Sketch. 538.13KB
PAA Virtual Investor Briefing PresentationPRICE SENSITIVE10/06/20 download Created with Sketch. 2.15MB
PAA Reinstatement to Official QuotationPRICE SENSITIVE04/06/20 download Created with Sketch. 212.66KB
PAA Preliminary Positive Results for the Treatment of SARS-CoV-2PRICE SENSITIVE04/06/20 download Created with Sketch. 611.92KB
PAA Suspension from Official QuotationPRICE SENSITIVE02/06/20 download Created with Sketch. 345.13KB
PAA Trading HaltPRICE SENSITIVE29/05/20 download Created with Sketch. 216.92KB
PAA Pause in TradingPRICE SENSITIVE29/05/20 download Created with Sketch. 116.22KB
PAA Monepantel Trial Achieves Successful Anti-Cancer OutcomePRICE SENSITIVE12/05/20 download Created with Sketch. 414.2KB
PAA Trading HaltPRICE SENSITIVE08/05/20 download Created with Sketch. 204.4KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE20/04/20 download Created with Sketch. 402.02KB
PAA PharmAust to Evaluate Monepantel on COVID-19PRICE SENSITIVE17/04/20 download Created with Sketch. 201.81KB
PAA Brisbane Animal Hospital Joins Phase II Dog Cancer TrialPRICE SENSITIVE03/03/20 download Created with Sketch. 187.06KB
PAA Appendix 4D & Half Year ReportPRICE SENSITIVE28/02/20 download Created with Sketch. 611.34KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE28/01/20 download Created with Sketch. 350.98KB
PAA PharmAust Receives $700k R&D Tax Incentive RefundPRICE SENSITIVE14/01/20 download Created with Sketch. 158.09KB
PAA Epichem Awarded One-Year Contract Extension from DNDiPRICE SENSITIVE08/01/20 download Created with Sketch. 190.71KB
PAA Epichem client gives notice to end contract in February 2020PRICE SENSITIVE07/01/20 download Created with Sketch. 170.1KB
PAA Expanded Site Recruitment for Phase II MPL Dog Cancer TrialPRICE SENSITIVE11/12/19 download Created with Sketch. 200.45KB
PAA Presentation - Pitt Street Research Life Sciences ConferencePRICE SENSITIVE28/11/19 download Created with Sketch. 3.66MB
PAA Progress in Recruitment for Phase II Trial in DogsPRICE SENSITIVE04/11/19 download Created with Sketch. 202.45KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE01/11/19 download Created with Sketch. 261.26KB
PAA AGM PresentationPRICE SENSITIVE25/10/19 download Created with Sketch. 3.58MB
PAA Epichem new CEO and Board additionsPRICE SENSITIVE14/10/19 download Created with Sketch. 242.4KB
PAA Appendix 3B & s708 NoticePRICE SENSITIVE10/10/19 download Created with Sketch. 413.53KB
PAA PharmAust Receives Pre-Approval for R&D Tax RebatesPRICE SENSITIVE07/10/19 download Created with Sketch. 165.83KB
PAA Epichem Export Business Receives Important WA State AwardsPRICE SENSITIVE04/10/19 download Created with Sketch. 159.63KB
PAA PharmAust Raises $2.4m in PlacementPRICE SENSITIVE03/10/19 download Created with Sketch. 156.44KB
PAA Trading HaltPRICE SENSITIVE01/10/19 download Created with Sketch. 203.13KB
PAA Agreement with Uni of Melbourne U-Vet for Phase II Dog TrialPRICE SENSITIVE10/09/19 download Created with Sketch. 186.95KB
PAA Phase II Dog Cancer Trial CommencesPRICE SENSITIVE09/09/19 download Created with Sketch. 176.58KB
PAA Investor Roadshow Presentation - September 2019PRICE SENSITIVE09/09/19 download Created with Sketch. 1.03MB
PAA Preliminary Final ReportPRICE SENSITIVE30/08/19 download Created with Sketch. 323.11KB
PAA Receipt of GMP Grade Tablets for Phase II TrialsPRICE SENSITIVE26/08/19 download Created with Sketch. 174.14KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE31/07/19 download Created with Sketch. 261.23KB
PAA Response to ASX Price and Volume QueryPRICE SENSITIVE23/07/19 download Created with Sketch. 252.39KB
PAA Pause In TradingPRICE SENSITIVE23/07/19 download Created with Sketch. 116.1KB
PAA PharmAust receives ethics approval to begin Phase II TrialPRICE SENSITIVE15/07/19 download Created with Sketch. 145.18KB
PAA Epichem Final Loan Repayment Milestone for New LaboratoryPRICE SENSITIVE02/07/19 download Created with Sketch. 144.77KB
PAA PharmAust Commences GMP Tablet Manufacture for Phase 2 TrialPRICE SENSITIVE04/06/19 download Created with Sketch. 148.74KB
PAA Receipt of 25kg of GMP-Grade Monepantel from ElancoPRICE SENSITIVE08/05/19 download Created with Sketch. 138.52KB
PAA Phase I Canine Repeat Dose MPL Demonstrates High PerformancePRICE SENSITIVE06/05/19 download Created with Sketch. 144.23KB
PAA Appendix 4C and Quarterly UpdatePRICE SENSITIVE01/05/19 download Created with Sketch. 262.98KB
PAA PharmAust Receives $672,250 R&D Tax Incentive RefundPRICE SENSITIVE30/04/19 download Created with Sketch. 141.27KB
PAA Shortfall Placement OversubscribedPRICE SENSITIVE11/04/19 download Created with Sketch. 154.7KB
PAA Phase I Monepantel Tablets Demonstrate High SafetyPRICE SENSITIVE28/03/19 download Created with Sketch. 146.46KB
PAA PharmAust Raises $1.3m in Rights IssuePRICE SENSITIVE22/03/19 download Created with Sketch. 158.69KB
PAA MPL Tablets Demonstrate Positive Performance in Phase 1PRICE SENSITIVE14/03/19 download Created with Sketch. 170.87KB
PAA PharmAust Rights Issue Reaches Minimum SubscriptionPRICE SENSITIVE12/03/19 download Created with Sketch. 152.62KB
PAA Appendix 4D & Financial ReportPRICE SENSITIVE01/03/19 download Created with Sketch. 1.03MB
PAA Offer Document - Rights IssuePRICE SENSITIVE26/02/19 download Created with Sketch. 266.27KB
PAA Phase I Dog Trial with New Monepantel Tablets CommencesPRICE SENSITIVE20/02/19 download Created with Sketch. 175.38KB
PAA Demonstration batch of smaller size MPL tablets completed
01/12/21PRICE SENSITIVE download Created with Sketch. 275.41KB
PAA MND & COVID-19 Phase 1 Clinical Trials On-Track
17/11/21PRICE SENSITIVE download Created with Sketch. 218.35KB
PAA Canine phase 2b cancer trial expands to New Zealand
15/11/21PRICE SENSITIVE download Created with Sketch. 234.84KB
PAA Appendix 4C and Quarterly Update
29/10/21PRICE SENSITIVE download Created with Sketch. 654.8KB
PAA MPL Manufacturing and Human Trials Update
21/10/21PRICE SENSITIVE download Created with Sketch. 223.25KB
PAA Following Extension of Survival, PAA Prepares Phase 3 Trial
18/10/21PRICE SENSITIVE download Created with Sketch. 247.8KB
PAA Prospectus
01/10/21PRICE SENSITIVE download Created with Sketch. 310.07KB
PAA Entitlement Options Offer
01/10/21PRICE SENSITIVE download Created with Sketch. 146.97KB
PAA Epichem Completes Final Loan Repayment
31/08/21PRICE SENSITIVE download Created with Sketch. 224.72KB
PAA Appendix 4E & Full Year Statutory Accounts
18/08/21PRICE SENSITIVE download Created with Sketch. 1.12MB
PAA Epichem Completes Build of OHD Benchtop Flow Reactor
03/08/21PRICE SENSITIVE download Created with Sketch. 211.58KB
PAA Appendix 4C and Quarterly Update
28/07/21PRICE SENSITIVE download Created with Sketch. 522.09KB
PAA Monepantel and monepantel sulfone COVID-19 anti-viral update
26/07/21PRICE SENSITIVE download Created with Sketch. 503.52KB
PAA PharmAust and WEHI to Investigate HTLV-1 Viral Infections
12/07/21PRICE SENSITIVE download Created with Sketch. 410.42KB
PAA Phase IIb Dog Trial Achieves Interim Clinical Endpoints
28/06/21PRICE SENSITIVE download Created with Sketch. 447.83KB
PAA PharmAust receives ethics approval for Phase I trial in MND
02/06/21PRICE SENSITIVE download Created with Sketch. 272.66KB
PAA Appendix 4C and Quarterly Update
29/04/21PRICE SENSITIVE download Created with Sketch. 305.76KB
PAA Phase IIb Canine Trial Identifies Therapeutic Window for MPL
27/04/21PRICE SENSITIVE download Created with Sketch. 367.01KB
PAA PharmAust Receives $750k R&D Tax Incentive Refund
08/04/21PRICE SENSITIVE download Created with Sketch. 348.54KB
PAA Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
07/04/21PRICE SENSITIVE download Created with Sketch. 531.65KB
PAA Trading Halt
06/04/21PRICE SENSITIVE download Created with Sketch. 412.74KB
PAA Pause in Trading
06/04/21PRICE SENSITIVE download Created with Sketch. 116.36KB
PAA Update on Phase IIb Clinical Trial of Monepantel in Pet Dogs
30/03/21PRICE SENSITIVE download Created with Sketch. 392.54KB
PAA Licensing Agreement to Develop Waste to Fuels Technology
23/03/21PRICE SENSITIVE download Created with Sketch. 324.8KB
PAA Appendix 4D & Half Year Report
26/02/21PRICE SENSITIVE download Created with Sketch. 523.81KB
PAA Update on Phase IIb Clinical Trial recruitment
15/02/21PRICE SENSITIVE download Created with Sketch. 346.6KB
PAA Appendix 4C and Quarterly Update
27/01/21PRICE SENSITIVE download Created with Sketch. 490.75KB
PAA Epichem Awarded $200K WasteSorted e-Waste Grant
22/01/21PRICE SENSITIVE download Created with Sketch. 389.54KB
PAA Leiden University Medical Centre Monepantel COVID-19 Testing
08/01/21PRICE SENSITIVE download Created with Sketch. 408.85KB
PAA PAA & ONJCRI to Continue MPL Pre-clinical Investigations
05/01/21PRICE SENSITIVE download Created with Sketch. 400.86KB
PAA PAA Commences Manufacture of GMP-Grade MPL for Human Trials
23/12/20PRICE SENSITIVE download Created with Sketch. 388.13KB
PAA PharmAust to Commence Phase IIb Dog Cancer Trial
22/12/20PRICE SENSITIVE download Created with Sketch. 369.9KB
PAA Epichem Awarded Contract Extension from DNDi
21/12/20PRICE SENSITIVE download Created with Sketch. 402.45KB
PAA Appendix 4C and Quarterly Update
29/10/20PRICE SENSITIVE download Created with Sketch. 275.91KB
PAA ONJCRI Evaluates Monepantel Anti-Cancer Mechanism
29/09/20PRICE SENSITIVE download Created with Sketch. 390.86KB
PAA PAA Evaluate MPL Suitability for Ex-Vivo Human COVID-19 Test
24/09/20PRICE SENSITIVE download Created with Sketch. 407.01KB
PAA PAA awarded grant for Phase I trial in Motor Neurone Disease
21/09/20PRICE SENSITIVE download Created with Sketch. 406.07KB
PAA PharmAust Shareholder Update
14/09/20PRICE SENSITIVE download Created with Sketch. 330.82KB
PAA Monepantel Anti-viral Activity Against SARS-CoV-2 Confirmed
09/09/20PRICE SENSITIVE download Created with Sketch. 398.64KB
PAA Elanco Option Update
09/09/20PRICE SENSITIVE download Created with Sketch. 373.81KB
PAA Trading Halt
07/09/20PRICE SENSITIVE download Created with Sketch. 536.33KB
PAA Epichem in partnership to develop waste into fuel technology
01/09/20PRICE SENSITIVE download Created with Sketch. 368.83KB
PAA Appendix 4E & Preliminary Final Report
31/08/20PRICE SENSITIVE download Created with Sketch. 313.61KB
PAA Inhibition of SARS-CoV-2 by MPL in Human Respiratory Cells
25/08/20PRICE SENSITIVE download Created with Sketch. 421.74KB
PAA Appendix 4C and Quarterly Update
28/07/20PRICE SENSITIVE download Created with Sketch. 475.64KB
PAA PharmAust Shareholder Update
24/06/20PRICE SENSITIVE download Created with Sketch. 955.83KB
PAA Reinstatement to Official Quotation
18/06/20PRICE SENSITIVE download Created with Sketch. 71.7KB
PAA Confirmation of Preliminary COVID-19 Results
18/06/20PRICE SENSITIVE download Created with Sketch. 868.39KB
PAA Voluntary Suspension
15/06/20PRICE SENSITIVE download Created with Sketch. 183.09KB
PAA Trading Halt
11/06/20PRICE SENSITIVE download Created with Sketch. 538.13KB
PAA Virtual Investor Briefing Presentation
10/06/20PRICE SENSITIVE download Created with Sketch. 2.15MB
PAA Reinstatement to Official Quotation
04/06/20PRICE SENSITIVE download Created with Sketch. 212.66KB
PAA Preliminary Positive Results for the Treatment of SARS-CoV-2
04/06/20PRICE SENSITIVE download Created with Sketch. 611.92KB
PAA Suspension from Official Quotation
02/06/20PRICE SENSITIVE download Created with Sketch. 345.13KB
PAA Trading Halt
29/05/20PRICE SENSITIVE download Created with Sketch. 216.92KB
PAA Pause in Trading
29/05/20PRICE SENSITIVE download Created with Sketch. 116.22KB
PAA Monepantel Trial Achieves Successful Anti-Cancer Outcome
12/05/20PRICE SENSITIVE download Created with Sketch. 414.2KB
PAA Trading Halt
08/05/20PRICE SENSITIVE download Created with Sketch. 204.4KB
PAA Appendix 4C and Quarterly Update
20/04/20PRICE SENSITIVE download Created with Sketch. 402.02KB
PAA PharmAust to Evaluate Monepantel on COVID-19
17/04/20PRICE SENSITIVE download Created with Sketch. 201.81KB
PAA Brisbane Animal Hospital Joins Phase II Dog Cancer Trial
03/03/20PRICE SENSITIVE download Created with Sketch. 187.06KB
PAA Appendix 4D & Half Year Report
28/02/20PRICE SENSITIVE download Created with Sketch. 611.34KB
PAA Appendix 4C and Quarterly Update
28/01/20PRICE SENSITIVE download Created with Sketch. 350.98KB
PAA PharmAust Receives $700k R&D Tax Incentive Refund
14/01/20PRICE SENSITIVE download Created with Sketch. 158.09KB
PAA Epichem Awarded One-Year Contract Extension from DNDi
08/01/20PRICE SENSITIVE download Created with Sketch. 190.71KB
PAA Epichem client gives notice to end contract in February 2020
07/01/20PRICE SENSITIVE download Created with Sketch. 170.1KB
PAA Expanded Site Recruitment for Phase II MPL Dog Cancer Trial
11/12/19PRICE SENSITIVE download Created with Sketch. 200.45KB
PAA Presentation - Pitt Street Research Life Sciences Conference
28/11/19PRICE SENSITIVE download Created with Sketch. 3.66MB
PAA Progress in Recruitment for Phase II Trial in Dogs
04/11/19PRICE SENSITIVE download Created with Sketch. 202.45KB
PAA Appendix 4C and Quarterly Update
01/11/19PRICE SENSITIVE download Created with Sketch. 261.26KB
PAA AGM Presentation
25/10/19PRICE SENSITIVE download Created with Sketch. 3.58MB
PAA Epichem new CEO and Board additions
14/10/19PRICE SENSITIVE download Created with Sketch. 242.4KB
PAA Appendix 3B & s708 Notice
10/10/19PRICE SENSITIVE download Created with Sketch. 413.53KB
PAA PharmAust Receives Pre-Approval for R&D Tax Rebates
07/10/19PRICE SENSITIVE download Created with Sketch. 165.83KB
PAA Epichem Export Business Receives Important WA State Awards
04/10/19PRICE SENSITIVE download Created with Sketch. 159.63KB
PAA PharmAust Raises $2.4m in Placement
03/10/19PRICE SENSITIVE download Created with Sketch. 156.44KB
PAA Trading Halt
01/10/19PRICE SENSITIVE download Created with Sketch. 203.13KB
PAA Agreement with Uni of Melbourne U-Vet for Phase II Dog Trial
10/09/19PRICE SENSITIVE download Created with Sketch. 186.95KB
PAA Phase II Dog Cancer Trial Commences
09/09/19PRICE SENSITIVE download Created with Sketch. 176.58KB
PAA Investor Roadshow Presentation - September 2019
09/09/19PRICE SENSITIVE download Created with Sketch. 1.03MB
PAA Preliminary Final Report
30/08/19PRICE SENSITIVE download Created with Sketch. 323.11KB
PAA Receipt of GMP Grade Tablets for Phase II Trials
26/08/19PRICE SENSITIVE download Created with Sketch. 174.14KB
PAA Appendix 4C and Quarterly Update
31/07/19PRICE SENSITIVE download Created with Sketch. 261.23KB
PAA Response to ASX Price and Volume Query
23/07/19PRICE SENSITIVE download Created with Sketch. 252.39KB
PAA Pause In Trading
23/07/19PRICE SENSITIVE download Created with Sketch. 116.1KB
PAA PharmAust receives ethics approval to begin Phase II Trial
15/07/19PRICE SENSITIVE download Created with Sketch. 145.18KB
PAA Epichem Final Loan Repayment Milestone for New Laboratory
02/07/19PRICE SENSITIVE download Created with Sketch. 144.77KB
PAA PharmAust Commences GMP Tablet Manufacture for Phase 2 Trial
04/06/19PRICE SENSITIVE download Created with Sketch. 148.74KB
PAA Receipt of 25kg of GMP-Grade Monepantel from Elanco
08/05/19PRICE SENSITIVE download Created with Sketch. 138.52KB
PAA Phase I Canine Repeat Dose MPL Demonstrates High Performance
06/05/19PRICE SENSITIVE download Created with Sketch. 144.23KB
PAA Appendix 4C and Quarterly Update
01/05/19PRICE SENSITIVE download Created with Sketch. 262.98KB
PAA PharmAust Receives $672,250 R&D Tax Incentive Refund
30/04/19PRICE SENSITIVE download Created with Sketch. 141.27KB
PAA Shortfall Placement Oversubscribed
11/04/19PRICE SENSITIVE download Created with Sketch. 154.7KB
PAA Phase I Monepantel Tablets Demonstrate High Safety
28/03/19PRICE SENSITIVE download Created with Sketch. 146.46KB
PAA PharmAust Raises $1.3m in Rights Issue
22/03/19PRICE SENSITIVE download Created with Sketch. 158.69KB
PAA MPL Tablets Demonstrate Positive Performance in Phase 1
14/03/19PRICE SENSITIVE download Created with Sketch. 170.87KB
PAA PharmAust Rights Issue Reaches Minimum Subscription
12/03/19PRICE SENSITIVE download Created with Sketch. 152.62KB
PAA Appendix 4D & Financial Report
01/03/19PRICE SENSITIVE download Created with Sketch. 1.03MB
PAA Offer Document - Rights Issue
26/02/19PRICE SENSITIVE download Created with Sketch. 266.27KB
PAA Phase I Dog Trial with New Monepantel Tablets Commences
20/02/19PRICE SENSITIVE download Created with Sketch. 175.38KB
(20min delay)
Last
18.0¢
Change
0.000(0.00%)
Mkt cap ! $71.26M
Open High Low Value Volume
18.0¢ 18.0¢ 17.0¢ $119.0K 679.3K

Buyers (Bids)

No. Vol. Price($)
4 235714 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 190570 5
View Market Depth
Last trade - 16.10pm 24/05/2024 (20 minute delay) ?
Last
18.0¢
  Change
0.000 ( 2.86 %)
Open High Low Volume
17.5¢ 18.0¢ 17.5¢ 48353
Last updated 15.51pm 24/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.